Skip to main content

European Communication on Research Awareness Needs

Objective

The ECRAN (European Communication on Research Awareness Needs) project is designed to develop a portfolio of open educational resources, including a film, for the general population about the challenges raised by independent clinical research.
The European Commission (FP7 Health Priority) decided to allocate substantial funding to independent (investigator-driven) clinical trials. Together with member states, the FP7 infrastructure unit supports the preparation and operation of a pan-European infrastructure for clinical trials (ECRIN). Through these instruments, Europe has the capacity to design and conduct independent, multinational clinical trials.
The objective of the ECRAN project is to develop tools to communicate key messages to citizens, patients, healthcare professionals, researchers, policymakers and society about independent, multinational clinical research. These messages will focus on:
i) the importance of public understanding of the need for and basic principles of clinical trials, fostering active involvement of patients in trials and of their representatives in trial design;
ii) the need for independent clinical trials driven by healthcare issues, to optimise treatment strategies through comparison of benefits and harms of multiple therapeutic options, supporting evidence-based clinical practice and reduction in healthcare inequalities;
iii) the need for transparency and optimal use of data, to promote the cost-effectiveness of treatments and to reduce the economic burden of diseases;
iv) the need for multinational cooperation, taking advantage of Europe’s population size and diversity, and of its medical expertise.
These objectives will be addressed using communication tools, including: a website, with an online database of open educational resources in different European languages; a film on clinical trials, dubbed in many languages, which is envisaged as a keystone of this initiative; an international event on multinational clinical trials.

Call for proposal

FP7-HEALTH-2012-INNOVATION-1
See other projects for this call

Coordinator

ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Address
Via Mario Negri 2
20156 Milano
Italy
Activity type
Research Organisations
EU contribution
€ 295 764
Administrative Contact
Maria Grazia Pezzoni (Ms.)

Participants (8)

ZADIG SRL
Italy
EU contribution
€ 182 362
Address
Via Ampere Andrea Maria 59
20131 Milano
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Roberto Satolli (Dr.)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 25 680
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
Administrative Contact
Lyddie Laaland (Mrs.)
OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
United Kingdom
EU contribution
€ 21 770
Address
Headley Way The John Radcliffe Hospital
OX39DU Headington
Activity type
Research Organisations
Administrative Contact
Martin Burton (Mr.)
THE COCHRANE COLLABORATION
United Kingdom
EU contribution
€ 116 630
Address
St Alban House 57-59 Haymarket
SW1Y 1QX London
Activity type
Other
Administrative Contact
David Tovey (Dr.)
REGION HOVEDSTADEN
Denmark
EU contribution
€ 173 420
Address
Kongens Vaenge 2
3400 Hillerod
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Administrative Contact
Berit Grevstad
UNIVERSITAETSKLINIKUM FREIBURG
Germany
EU contribution
€ 25 680
Address
Hugstetter Strasse 49
79106 Freiburg
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Jürgen Dreyer (Mr.)
EUROPEAN AIDS TREATMENT GROUP EV
Germany
EU contribution
€ 25 680
Address
Mettmanner Strasse 24-26
40233 Dusseldorf
Activity type
Other
Administrative Contact
Koen Block (Mr.)
KLINIKUM DER UNIVERSITAET ZU KOELN
Germany
EU contribution
€ 25 680
Address
Kerpener Strasse 62
50937 Koeln
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Insa Bruns